CN Patent

CN117122701B — 一种氯化钾颗粒制剂及其制备方法

Assigned to Hebei Sanhe Shichuang Biotechnology Co ltd · Expires 2024-04-19 · 2y expired

What this patent protects

本发明公开了一种氯化钾颗粒制剂及其制备方法,属于医药制剂技术领域,该颗粒制剂具体包括氯化钾包合物,甘油磷酸钙,润滑剂和矫味剂;其中,所述氯化钾包合物包括氯化钾和葡糖基‑环糊精。本发明氯化钾颗粒制剂制备工艺顺畅,含量均匀度高,易于分次用药,保证患者用药的安全有效,适合工业化大规模生产。

USPTO Abstract

本发明公开了一种氯化钾颗粒制剂及其制备方法,属于医药制剂技术领域,该颗粒制剂具体包括氯化钾包合物,甘油磷酸钙,润滑剂和矫味剂;其中,所述氯化钾包合物包括氯化钾和葡糖基‑环糊精。本发明氯化钾颗粒制剂制备工艺顺畅,含量均匀度高,易于分次用药,保证患者用药的安全有效,适合工业化大规模生产。

Drugs covered by this patent

Patent Metadata

Patent number
CN117122701B
Jurisdiction
CN
Classification
Expires
2024-04-19
Drug substance claim
No
Drug product claim
No
Assignee
Hebei Sanhe Shichuang Biotechnology Co ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.